Cardiol Therapeutics Inc at Emerging Growth Conference Transcript
Welcome, everybody. Good morning, good evening, good afternoon, wherever this is finding you, I hope you're well. Welcome to the 31st Emerging Growth Conference. I'm Ana Berry. I'll be your host today. So as always, we have an exciting list of companies in a wide range of growth sectors presenting to you today.
(Conference Instructions)
Today, we have nine companies presenting. So, without further ado, I will introduce our first, please welcome Cardiol Therapeutics Inc. It trades on the Nasdaq under the symbol, CRDL and on the TSX under the symbol, CRDL. And is a clinical-stage life sciences company focused on the research and clinical development of cannabinoid and an antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease. Please welcome its CEO, David Elsley.
Welcome, David. How are you doing today?
I'm doing great. Thanks very much for having us here today. It's a great -- very thrilled to have the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |